| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Emster Kurt Von is a Director at PCVX with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $363.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 22,781 | $19.42 | $442,403.40 | -0.6% | |
| Aug 23, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 17,989 | $18.53 | $333,336.17 | -0.4% | |
| Aug 21, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 3,150 | $18.52 | $58,344.50 | - | |
| Aug 17, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 34,141 | $19.06 | $650,692.78 | -0.8% | |
| Aug 15, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 55,569 | $19.59 | $1,088,560.70 | -1.3% | |
| Aug 8, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 35,473 | $18.63 | $660,887.69 | -0.8% | |
| Aug 4, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 50,477 | $17.81 | $899,215.93 | -1.1% | |
| Aug 1, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 5,512 | $17.51 | $96,491.49 | -0.1% | |
| Jul 28, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 41,312 | $17.63 | $728,134.00 | -0.9% | |
| Jul 26, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 32,930 | $17.60 | $579,545.44 | -0.7% |